Friday, September 8, 2017 News Recap: She thought her mystery ailment was cancer, but bloodwork revealed a surprise This is an amazing story ...but it could happen to anyone, and we know this because we hear these kinds of stories often. This is why it is so important that Boomers be tested for hepatitis C. Gail Wells got really sick and nobody could figure out why. They looked for cancer, for multiple sclerosis, for vitamin deficiencies, and then s...
A new study indicates that direct-acting antiviral therapy is safe and effective in patients with chronic kidney disease (CKD) and Hepatitis C virus (HCV) infection. The study, which appears in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN), also found that treatment may help improve some patients' kidney function. HCV infection—which often causes liver disease—is common in patients with CKD, and it increases their
Friday, February 3, 2017 News Recap Hepatitis C and Rheumatic, Kidney & Heart Disease As you may remember there have been quite a few news items over the past few months about the extrahepatic effects of hepatitis C, which is more and more coming to be recognized as a multi-organ disease. Not only is the hepatitis C virus (HCV) the cause of liver diseases in up to 170 million people worldwide, it also has many extrahepatic disease manifestation...
Be sure to check out this webinar video from the American Liver Foundation in collaboration with the National Kidney Foundation in the USA
If effective, the new approach could make a dent in the kidney waiting list, where about 5 percent of patients die each year. Last month, Kiran Shelat let University of Pennsylvania surgeons replace his failing kidneys with one that they knew would infect him with hepatitis C, a virus that could slowly destroy his liver. Normally, a kidney infected with hep C would be offered only to transplant patients who already have the disease -- or thrown away.
HCV infection increases end-stage renal disease (ESRD) risk among patients with diabetes. [Editor's note: This review and commentary includes study data presented at the 53rd Congress of the European Renal Association-European Dialysis & Transplant Association (ERA-EDTA 2016) in Vienna, Austria, May 21-24. 2016, and reflects discussions that took place at the congress.] Infection with the hepatitis C virus (HCV) affects more than 170 million people
Treatment with direct-acting antivirals not only cures people of hepatitis C, but can also rapidly reduce the severity of one of the most troublesome extrahepatic manifestations of the disease, a study published this month shows.Although studies of direct-acting antivirals show that newly-licensed combinations can cure hepatitis C in 90 to 95% of people, there is less information about the extent to which curing hepatitis C leads to improvements in the hea
HepCBC is seeking individual patient input for our submission to the federal government for an INTERFERON-FREE, ONE PILL/DAY drug combo, shown to be effective for genotypes 1, 3, 4, and 6, Merck Pharmaceutical's elbasvir + grazoprevir (± ribavirin). The treatment's success (96% - 100% SVR12) has been confirmed in trials including people considered 'hard to treat' including those who had failed previous treatment (including simeprevir, boceprevir, and telap